Guardian Pharmacy Services entered into lock-up agreements with founders, executive officers, and certain employees effective September 10, 2026. Approximately 29.9 million shares of Class A common stock held by these Lock-Up Holders are subject to the restrictions, representing about 81% of pre-IPO insider holdings after giving effect to the conversion of Class B shares. The lock-up period extends through September 14, 2027. On September 27, 2026, the final tranche of Class B common stock will automatically convert into 13,521,396 shares of Class A common stock, bringing total outstanding shares to 63,320,300. Guardian Pharmacy Services operates in the pharmacy services industry.